201 related articles for article (PubMed ID: 36232559)
41. Expanding diagnostic criteria: Multiorgan T-Cell/myeloid mixed phenotype acute leukemia with t(v;11q23)
Syed S; Song A; Hussaini M
Leuk Res Rep; 2022; 17():100306. PubMed ID: 35356416
[TBL] [Abstract][Full Text] [Related]
42. Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment.
Alexander TB; Orgel E
Curr Oncol Rep; 2021 Feb; 23(2):22. PubMed ID: 33544265
[TBL] [Abstract][Full Text] [Related]
43. RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.
Gaidzik VI; Bullinger L; Schlenk RF; Zimmermann AS; Röck J; Paschka P; Corbacioglu A; Krauter J; Schlegelberger B; Ganser A; Späth D; Kündgen A; Schmidt-Wolf IG; Götze K; Nachbaur D; Pfreundschuh M; Horst HA; Döhner H; Döhner K
J Clin Oncol; 2011 Apr; 29(10):1364-72. PubMed ID: 21343560
[TBL] [Abstract][Full Text] [Related]
44. Acute myeloid leukemia with myelodysplasia-related changes and blasts of the mixed T/myeloid phenotype: a case report.
Sheng XF; Hong LL; Huang FY; Zhuang HF
J Int Med Res; 2022 Sep; 50(9):3000605221122741. PubMed ID: 36134564
[TBL] [Abstract][Full Text] [Related]
45. The genomic and biological complexity of mixed phenotype acute leukemia.
Andrews C; Tierens A; Minden M
Crit Rev Clin Lab Sci; 2021 May; 58(3):153-166. PubMed ID: 33161794
[TBL] [Abstract][Full Text] [Related]
46. Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
Lazzarotto D; Tanasi I; Vitale A; Piccini M; Dargenio M; Giglio F; Forghieri F; Fracchiolla N; Cerrano M; Todisco E; Papayannidis C; Leoncin M; Defina M; Guolo F; Pasciolla C; Delia M; Chiusolo P; Mulè A; Candoni A; Bonifacio M; Pizzolo G; Foà R
Ann Hematol; 2023 May; 102(5):1099-1109. PubMed ID: 36959485
[TBL] [Abstract][Full Text] [Related]
47. T/Myeloid Mixed-Phenotype Acute Leukemia with Basophilia.
Kong L; Zhao L; Guo Y
Clin Lab; 2023 Mar; 69(3):. PubMed ID: 36912307
[TBL] [Abstract][Full Text] [Related]
48. Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.
Cernan M; Szotkowski T; Pikalova Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):234-241. PubMed ID: 28422191
[TBL] [Abstract][Full Text] [Related]
49. Multiparametric Flow Cytometry in Mixed Phenotype Acute Leukemia.
Koulmane Laxminarayana SL; Madireddy N; Manohar C; Udupa K
Indian J Hematol Blood Transfus; 2019 Jul; 35(3):451-458. PubMed ID: 31388256
[TBL] [Abstract][Full Text] [Related]
50. Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations.
Mi X; Griffin G; Lee W; Patel S; Ohgami R; Ok CY; Wang S; Geyer JT; Xiao W; Roshal M; Garcia JS; Silverman LB; Sallan SE; Aster JC; Harris MH; Weinberg OK
Am J Hematol; 2018 Nov; 93(11):1358-1367. PubMed ID: 30117174
[TBL] [Abstract][Full Text] [Related]
51. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.
Weinberg OK; Seetharam M; Ren L; Alizadeh A; Arber DA
Am J Clin Pathol; 2014 Dec; 142(6):803-8. PubMed ID: 25389334
[TBL] [Abstract][Full Text] [Related]
52. Multiple cells of origin in common with various types of mouse N-Myc acute leukemia.
Bai H; Zhang Q; Zhang S; Wang J; Luo B; Dong Y; Gao J; Cheng T; Dong F; Ema H
Leuk Res; 2022 Jun; 117():106843. PubMed ID: 35512442
[TBL] [Abstract][Full Text] [Related]
53. Mixed-phenotypic acute leukemia series from tertiary care center.
Pawar RN; Banerjee S; Bramha S; Krishnan S; Bhattacharya A; Saha V; Chakrapani A; Bhave S; Chandy M; Nair R; Parihar M; Arora N; Mishra DK
Indian J Pathol Microbiol; 2017; 60(1):43-49. PubMed ID: 28195090
[TBL] [Abstract][Full Text] [Related]
54. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
[TBL] [Abstract][Full Text] [Related]
55. Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated
Nguyen L; Zhang X; Roberts E; Yun S; McGraw K; Abraham I; Song J; Braswell D; Qin D; Sallman DA; Lancet JE; List AF; Moscinski LC; Padron E; Zhang L
Leuk Lymphoma; 2020 Jun; 61(6):1395-1405. PubMed ID: 32091281
[TBL] [Abstract][Full Text] [Related]
56. Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation.
Liu S; Cui Q; Dai H; Song B; Cui W; Xue S; Qiu H; Miao M; Jin Z; Li C; Fu C; Wang Y; Sun A; Chen S; Zhu X; Wu D; Tang X
Transplant Cell Ther; 2021 Jun; 27(6):481.e1-481.e7. PubMed ID: 33785365
[TBL] [Abstract][Full Text] [Related]
57. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
58. Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias.
Rocquain J; Carbuccia N; Trouplin V; Raynaud S; Murati A; Nezri M; Tadrist Z; Olschwang S; Vey N; Birnbaum D; Gelsi-Boyer V; Mozziconacci MJ
BMC Cancer; 2010 Aug; 10():401. PubMed ID: 20678218
[TBL] [Abstract][Full Text] [Related]
59. Clinical and molecular characteristics of acute myeloid leukemia and the dismal prognosis of
Liu H; Shi Y; Tao S; Li Y; Wang C; Yu L
Hematology; 2023 Dec; 28(1):2223866. PubMed ID: 37313982
[TBL] [Abstract][Full Text] [Related]
60. RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.
Greif PA; Konstandin NP; Metzeler KH; Herold T; Pasalic Z; Ksienzyk B; Dufour A; Schneider F; Schneider S; Kakadia PM; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK
Haematologica; 2012 Dec; 97(12):1909-15. PubMed ID: 22689681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
